ICU Medical Current Ratio 2006-2019 | ICUI

ICU Medical current ratio from 2006 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
ICU Medical Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-06-30 $0.93B $0.26B 3.58
2019-03-31 $0.92B $0.24B 3.86
2018-12-31 $0.93B $0.25B 3.72
2018-09-30 $0.91B $0.20B 4.51
2018-06-30 $0.90B $0.20B 4.44
2018-03-31 $0.87B $0.20B 4.37
2017-12-31 $0.87B $0.21B 4.11
2017-09-30 $0.91B $0.20B 4.65
2017-06-30 $0.90B $0.19B 4.78
2017-03-31 $0.89B $0.16B 5.52
2016-12-31 $0.57B $0.04B 14.04
2016-09-30 $0.50B $0.03B 15.47
2016-06-30 $0.54B $0.04B 13.18
2016-03-31 $0.52B $0.03B 15.16
2015-12-31 $0.51B $0.04B 11.85
2015-09-30 $0.51B $0.04B 13.81
2015-06-30 $0.47B $0.03B 16.43
2015-03-31 $0.45B $0.03B 13.80
2014-12-31 $0.43B $0.03B 15.06
2014-09-30 $0.43B $0.03B 14.51
2014-06-30 $0.41B $0.03B 15.21
2014-03-31 $0.40B $0.03B 15.71
2013-12-31 $0.39B $0.03B 14.67
2013-09-30 $0.36B $0.03B 13.44
2013-06-30 $0.35B $0.03B 12.35
2013-03-31 $0.33B $0.03B 13.07
2012-12-31 $0.33B $0.03B 11.18
2012-09-30 $0.31B $0.03B 10.81
2012-06-30 $0.29B $0.03B 9.84
2012-03-31 $0.28B $0.03B 10.87
2011-12-31 $0.26B $0.03B 8.89
2011-09-30 $0.24B $0.02B 9.85
2011-06-30 $0.24B $0.03B 8.92
2011-03-31 $0.22B $0.03B 8.07
2010-12-31 $0.21B $0.03B 7.97
2010-09-30 $0.20B $0.03B 7.34
2010-06-30 $0.18B $0.03B 5.88
2010-03-31 $0.18B $0.03B 5.86
2009-12-31 $0.21B $0.03B 6.17
2009-09-30 $0.21B $0.02B 8.96
2009-06-30 $0.21B $0.02B 9.91
2009-03-31 $0.19B $0.02B 8.36
2008-12-31 $0.18B $0.02B 8.17
2008-09-30 $0.18B $0.02B 8.10
2008-06-30 $0.17B $0.02B 7.95
2008-03-31 $0.16B $0.02B 7.74
2007-12-31 $0.15B $0.02B 7.14
2007-09-30 $0.16B $0.02B 7.92
2007-06-30 $0.17B $0.02B 8.57
2007-03-31 $0.17B $0.02B 10.81
2006-12-31 $0.17B $0.02B 10.77
2006-09-30 $0.17B $0.02B 9.45
2006-06-30 $0.16B $0.02B 9.49
2006-03-31 $0.15B $0.01B 10.23
2005-12-31 $0.14B $0.01B 9.92
2005-09-30 $0.13B $0.01B 8.85
2005-06-30 $0.12B $0.01B 8.39
2005-03-31 $0.13B $0.01B 14.16
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $3.322B $1.400B
ICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. They are one of the world's leading pure-play infusion therapy companies, with global operations and a wide-ranging product portfolio that includes IV solutions, IV smart pumps, dedicated and non-dedicated IV sets and needlefree connectors, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. In addition, they manufacture automated pharmacy IV compounding systems with workflow technology, closed systems transfer devices for hazardous IV drugs, and cardiac monitoring systems to optimize patient fluid levels.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $147.825B 27.79
Medtronic (MDT) Ireland $147.584B 20.72
Stryker (SYK) United States $82.482B 28.52
Boston Scientific (BSX) United States $59.759B 28.99
Baxter (BAX) United States $44.643B 27.07
EssilorLuxottica Societe Anonyme (ESLOY) France $31.425B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.623B 18.32
Coloplast (CLPBY) Denmark $25.682B 41.00
Lonza Group Ag (LZAGY) Switzerland $25.628B 0.00
Terumo (TRUMY) Japan $22.710B 26.11
Smith & Nephew SNATS (SNN) United Kingdom $20.792B 0.00
ResMed (RMD) United States $19.048B 36.32
Sunny Optical Technology (SNPTF) China $16.288B 0.00
Bio-Rad Laboratories (BIO) United States $10.082B 54.05
Canopy Growth (CGC) Canada $10.015B 0.00
Insulet (PODD) United States $8.923B 528.71
Perrigo (PRGO) Ireland $7.527B 13.86
William Demant Holdings (WILYY) Denmark $7.386B 0.00
Hill-Rom Holdings (HRC) United States $6.973B 20.79
Haemonetics (HAE) United States $6.488B 48.96
GN STORE NORD (GNNDY) Denmark $5.570B 28.78
Aurora Cannabis (ACB) Canada $5.377B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $4.192B 0.00
Neogen (NEOG) United States $4.086B 67.83
NuVasive (NUVA) United States $3.383B 26.97
Hutchison China MediTech (HCM) China $2.766B 0.00
Quidel (QDEL) United States $2.645B 26.26
Agios Pharmaceuticals (AGIO) United States $2.144B 0.00
National Vision Holdings (EYE) United States $2.086B 45.03
Cardiovascular Systems (CSII) United States $1.794B 0.00
Aphria (APHA) $1.577B 0.00
VAREX IMAGING (VREX) United States $1.099B 25.32
AtriCure (ATRC) United States $1.000B 0.00
Lantheus Holdings (LNTH) United States $0.999B 26.25
Omeros (OMER) United States $0.912B 0.00
Phibro Animal Health (PAHC) United States $0.882B 14.34
NanoString Technologies (NSTG) United States $0.807B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.793B 20.22
Cerus (CERS) United States $0.744B 0.00
PetIQ (PETQ) United States $0.740B 17.47
LeMaitre Vascular (LMAT) United States $0.710B 42.09
MacroGenics (MGNX) United States $0.631B 0.00
Surmodics (SRDX) United States $0.623B 118.46
TG Therapeutics (TGTX) United States $0.609B 0.00
Quanterix (QTRX) United States $0.598B 0.00
OraSure Technologies (OSUR) United States $0.463B 21.43
Meridian Bioscience (VIVO) United States $0.413B 12.88
BioLife Solutions (BLFS) United States $0.399B 131.13
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.373B 0.00
Utah Medical Products (UTMD) United States $0.371B 27.17
Owens & Minor (OMI) United States $0.353B 10.59
Zynex (ZYXI) United States $0.304B 32.28
United Health Products (UEEC) United States $0.293B 0.00
Bovie Medical (APYX) United States $0.239B 0.00
Rockwell Medical (RMTI) United States $0.213B 0.00
Cytosorbents (CTSO) United States $0.174B 0.00
Vapotherm (VAPO) United States $0.171B 0.00
Chimerix (CMRX) United States $0.146B 0.00
Fonar (FONR) United States $0.143B 10.19
Female Health (VERU) United States $0.124B 0.00
Chembio Diagnostics (CEMI) United States $0.120B 0.00
InfuSystems Holdings (INFU) United States $0.102B 0.00
United-Guardian (UG) United States $0.088B 20.88
MRI Interventions (MRIC) United States $0.069B 0.00
Nephros (NEPH) United States $0.064B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.056B 0.00
Surface Oncology (SURF) United States $0.053B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
Trinity Biotech (TRIB) Ireland $0.033B 0.00
Senestech (SNES) United States $0.026B 0.00
GUARDION HEALTH (GHSI) United States $0.023B 0.00
Myomo (MYO) United States $0.013B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.013B 0.00
Capricor Therapeutics (CAPR) United States $0.011B 0.00
Valeritas Holdings (VLRX) United States $0.009B 0.00
Akers Biosciences Inc (AKER) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00